Venous ulceration: A cross-over study from nonoperative to operative treatment  by DePalma, Ralph G. & Kowallek, Donna L.
Venous ulceration: A cross-over study from 
nonoperative to operative treatment 
Ralph G. DePalma, MD,  FACS, and Donna L. Kowallek, MN,  RN,  ICS , Reno, Nev. 
Purpose: This study compared 3 years ofnonoperative therapy in a vascular clinic (1991 to 
1993) with a proactive approach to diagnosis and operative treatment (1994 to 1995). 
Methods: In the first period, 11 compliant men 48 to 69 years of age (average, 55 years) 
were treated without surgery using Unna's boot dressing, compression wound care, and 
patient education. In the second period, after duplex scans and venographic examinations 
when appropriate, operative interventions were performed in 10 patients. 
Results: In period I there were 44 occurrences ofulceration (range, 3 to 8 per individual), 
with an average time to heal of 13 weeks (range, 7 to 28 weeks per individual). Beginning 
in January 1994 (period 2), 11 patients who had current active ulceration underwent 
duplex scans and venographic examinations to detect correctable sions, including deep, 
superficial, or perforator incompetence, or deep venous occlusions. Ten became candidates 
for surgery. One patient was not a candidate for venous urgery because of extensive caval 
thrombosis. Operations included extrafascial perforator division in nine patients; long 
saphenous stripping with submaUeolar saphenous and perforator interruption in seven; 
one Palma crossover venous graft; and one superficial femoral vahafloplasty. In period 2 
(24 months), there were two recurrent ulcers, one related to failure to use adequate 
compression and one related to infection of an incision. Nine of 10 patients remained 
healed at 24 months. Average time to heal was 4 weeks. Clinical severity score as described 
in the Consensus Statement of the American Venous Forum was reduced from 12 (range, 
9 to 17) in period 1 to a mean of 3.5 (range, 2 to 8) in period 2 (p < 0.01 by paired t test). 
Conclusion: Improved diagnostic and operative techniques make possible more active 
approaches to venous ulceration. Nonoperative treatment, even in skilled hands, is 
associated with prolonged disability and ulcer recurrence. The condition of selected 
patients in whom nonoperative treatment fails can be improved substantially with 
operative intervention. (J Vasc Surg 1996;24:788-92.) 
The traditional treatment of venous ulceration 
that is advocated in the current literature remains 
nonoperative: xtremity elevation, graded compres- 
sion, wound care, and patient education) Clinical 
experience demonstrates that with nonoperative 
therapy most ulcers will heal over time. However, 
prolonged isability and recurrence of ulceration as a 
result of chronic venous insufficiency (CVI) remain 
important and unsolved issues. High rates of recur- 
rences have been reported from many centers despite 
highly sldlled care. For example, in a recent report 
Erickson et al. 2 described a 57% ulcer recurrence rate 
at a median of 10.4 months. Rates of healing and 
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recurrence were shown to relate to CVI severity as 
well as patient compliance. Our current study com- 
pared 3 years of intensive nonoperative therapy for a 
group of men who were treated for venous ulceration 
in a vascular clinic with a proactive approach of 
diagnosis and operative treatment. 
PAT IENTS AND METHODS 
In the vascular surgical clinic at the Department 
of Veterans Affairs Medical Center, Reno, Nev., 11 
men ranging in age from 43 to 64 years (average, 
55 years) were treated for venous ulceration without 
surgery for a period of 3 years from January 1991 
to December 1993 (period 1). This cohort of men 
was seen by vascular surgeons on a teaching service 
and was treated by an experienced vascular advanced 
nurse practitioner using Unna's paste boots for open 
ulceration, graded compression, elevation, and pa- 
tient education. Patient compliance for this group 
was high, as judged by the reliability of follow-up 
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Table I. Classification of venous dysfunction and clinical/disability scores in periods 1 and 2 
Clinical score Disability score 
Patient no. Class Age (yr) Period ] Period 2 Period i Period 2 
1 C6, Ep, A s 2,3, d13, Pls, Pr 44 11 " 2 2 0 
2 C6, Ep, A S 2,3, d13, P18, Pr 43 9 2 3 1 
3 C6, Es, Adl3, Pls, Pr 0 69 14 8 2 2* 
4 C6, Ep, As 2,s, Pr 43 10 2 2 " 1 
5 C6, Ep, As 2,3, Pls, Pr 46 14 3 3 1 
6 C6, Ep, A s 2,s, Pl8, Pr 62 12 3 2 1 
7 C6, Ep, As 2,3,d 13,14, Pls, I)r 58 13 3 3 2 
8 C6, Es, Ad 9, s13, P18, Por 61 17 6 3 2 
9 C6, Es, Aa 12,13, Po r 65 10 4 3 2 
10 C6, Ep, A s 2,3, d13, Pr 59 10 2 2 2 
*Retired: see text~ 
appointments (greater than 95%) and compliance 
with wearing of graded 30- to 40-mm Hg support 
in all cases. All patients had normal arterial circu- 
lation, as judged by normally palpable pulses and 
ankle-brachial indexes. 
Beginning in January 1994 (period 2), these 
patients were reevaluated by physical and Doppler 
examinations and were studied by color-flow duplex 
scanning 3 to assess the presence or absence of oc- 
clusive lesions or valvular insufficiency and to de- 
termine the involvement of particular venous seg- 
ments. To characterize anatomic lesions that were 
potentially amenable to corrective venous surgery, 
ascending ~ and descending phlebography 5 were per- 
formed in eight of the 10 patients to clarify the 
duplex findings. On the basis of the duplex and 
phlebographic observations, urgical interventions 
were performed in 10 of 11 men to ameliorate, as 
much as possible, the transmission of venous hy- 
pertension to the affected areas of skin. Ten of 11 
men were identified as having operable lesions; one 
was found to have a service-related xtensive throm- 
bosis of the inferior vena cava caused by a gunshot 
wound. This patient was not subjected to recon- 
structive or venoablative procedures. 
On the basis of duplex and vcnographic findings, 
all patients were classified using the new classification 
and grading (CEAP) of chronic venous disease pre- 
pared by an ad hoc committee of the American 
Venous Forum. 6In brief, Crelates to clinical signs: all 
patients were class 6 before surgery, that is, they had 
active current ulceration. Erelates to etiologic factors, 
primary or secondary; six patients were Ep and four 
patients were Es. A relates to anatomic distribution, 
including superficial, deep, or perforator obstruction 
of incompetence, alone or in combination. Prelates to 
pathophysiologic dysfunction, that is, reflux or ob- 
struction or in combination (Table I). Preoperative 
and postoperative clinical severity and disability scorcs 
provided by the CEAP method were calculated for 
each patient and compared in period 1 and period 2. 
Specifically concerning venous ulceration, the recur- 
rcnce rate per patient and average healing time per 
ulcer were compared between period 1 and period 2. 
Limbs were examined to verify the extent oflipoder- 
matosclerosis, and photographs were taken at appro- 
priate follow-up visits. 
Surgical procedures were performed according to 
the prcdominant disease pattern of CVI that was 
believed to contribute to ulceration in the particular 
paticnt. Thcsc proccdures werc based on the elimina- 
tion or amelioration of transmission ofelevated pres- 
sure to the areas of ulceration. 7'8 Heparin and prcop- 
erative and postoperative antibiotics were adminis- 
tered as previously described9; the regimen ofheparin 
was begun 24 hours after operative intervention and 
was continued at prophylactic doses of 5000 U 
subcutaneously every 12 hours until the patients was 
ambulatory. Before discharge all patients were again 
refitted with graded compression hose with 30 mm 
Hg ankle pressure. The following procedures were 
performed: extrafascial perforator division using 
shearing technique, that is, extrafascial subcutaneous 
venous interruption, 9'1° in nine patients, as well as 
submalleolar perforator and distal saphenous inter- 
ruption, 11 superficial femoral valvuloplasty 12 in one 
patient; saphenous vein stripping from ankle to groin 
in seven patients; and Palma crossover graft without 
arterial venous fistula for unilateral iliac vein occlusion 
in one patient, performed as a staged procedure. 
RESULTS 
No deaths or immediate surgical complications 
occurred. Nine of 10 patients remain ulcer-free at 12 
to 24 months (mean follow-up, 18 months). One 
infected incision in the submalleolar ea caused one 
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of the two ulcer recurrences in period 2. Neither 
recurrence r sulted in prolonged isability and will be 
further described. 
In period 1, the recurrence rate of ulceration was 
4.4 per patient (range, 3 to 8), with an average time to 
heal of 4 weeks. Before surgery, six of 10 patients were 
fully employed; one was retired at 69 years of age. 
After Surgery, nine of the 10 are now fully employed. 
The patient with the caval occlusion who was not 
chosen for venous intervention was given appropriate 
disability from his employment asa short-order cook. 
The caval occlusion was first detected as a result of 
phlebographic evaluation that was performed to de- 
lineate the source of his severe venous hypertension. 
Table I summarizes the clinical classification and 
grade according to the consensus tatement of the 
American Venous Forum, 6 along with preoperative 
and postoperative clinical severity scores and disability 
scores, also provided by the consensus statement. The 
clinical score is a quantitative method for estimating 
disease severity. It includes edema, venous claudica- 
tion, pigmentation, lipodermatosclerosis and ulcer 
duration, recurrence, and number. Each category is
rated for severity on a scale of 0 to 3, and the ratings 
are added. Our patients who had ulceration ranged in 
score from 9 to 17, which is a relatively high score, 
during the nonoperative phase. The change in mean 
clinical score from 12 in period 1 to 3.5 in period 2 
was significant (p < 0.01 by analysis of variance). 
Disability scores included 0, asymptomatic; 1, symp- 
tomatic but can work without a support device; 2, can 
work an 8-hour day with a support device; and 3, 
unable to work even with a support device. 
The two recurrences in period 2, although brief, 
require further description. Both occurred in patterns 
of CVI caused by obstruction. The first was caused by 
inframalleolar wound infection with Pseudomonas 
aeruginosa. Repeat duplex scanning and phlebo- 
graphic evaluation confirmed residual inframalleolar 
perforators, which were subsequently treated by sub- 
fascial endoscopic perforator surgery (SEPS) ~2,~3 and 
skin grafting. The patient is now fully ambulatory; the 
remaining superficial defect is 75% healed. 
The second recurrence began 10 months after 
extrafascial shearing preceded by a staged Palma 
crossover vein graft. The graft remains patent by 
duplex sonography. The ulcer was caused by derma- 
titis in the middle third of the leg and was related to 
the failure to replace the patient's now outdated 
compression hose. The affected area was treated by 
limited excision and skin graft, which required 7 days 
to heal. This patient returned to work within 4 weeks 
and remains healed at 24 months. 
DISCUSSION 
Clinical trials concerning the treatment of venous 
ulceration, as pointed out by Stacey, 14 are particularly 
difficult o evaluate. If treatment is to be evaluated, it 
is critical to use a control group that has had optimal 
nonoperative treatment, not a form of treatment that 
was suboptimal. Fortunately, at the time this study 
began a group of compliant patients was available for 
crossover into an operative treatment mode. Favor- 
able results appear clearly evident in terms of quanti- 
tative clinical outcomes. Although randomized con- 
trolled trials might be ideal for evaluating uniform 
surgical interventions, the multiplicity of factors that 
contribute to venous ulceration make uniform surgi- 
cal approaches difficult. It has been suggested that 
somewhat fewer than 40% of treatment evaluation 
questions can be assessed with randomized controlled 
trials. 15 Therefore, selection of a crossover study 
appeared to be particularly applicable to venous 
ulceration in compliant individuals in whom optimal 
nonoperative therapy failed. 
The results of crossover from nonoperative to 
operative intervention for CVI are encouraging. The 
opportunity to examine thoroughly and intervene 
definitively in a well-defined cohort of men with CVI 
related in no small part to skilled nursing care man- 
agement for 3 years during period 1. The favorable 
results in period 2 compare with the postoperative 
observations in 75 extremities who were observed 
long-term since 1980 with a recurrence rate of about 
10%. 7.9 Recently, diagnostic methods using color flow 
duplex scanning have contributed to a better delin- 
eation of venous dysfunction. 3 To select patients who 
are.suitable to undergo valvuloplasty, the techniques 
of ascending and descending venography described 
by Thomas 4and Kistner swere found to be of consid- 
erable utility. In one patient in this series, external 
valvuloplasty of the first two valves of the superficial 
femoral vein 16 relieved severe chronic stasis where this 
was the main reflux site. Kistner sgrade 4 reflux and a 
normally competent saphenous vein suggested this 
choice of procedure. In seven instances, the combi- 
nation of perforator incompetence and saphenous 
vein reflux were found to be associated with ulcer- 
ation. In these cases, saphenous vein stripping rather 
than femoral valvuloplasty was elected because 
saphenectomy has been shown to result in improved 
competence of the deep systems 
The financial and social impacts of venous ulcer- 
ation are considerable. Nonoperative treatment re- 
quires expertise and intensive medical resources that 
involve labor-intensive care and expensive supplies. 
Although obesity and age seem to be risk factors in 
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ulcer disease, in our group the average age was 55 
years, somewhat younger than the CVI group that 
was described in Scott's ~8 case control epidemiologic 
study, in which the average age was 59 years. None 
of the patients in our operative group was obese. 
Proactive efforts for diagnosis and treatment ap- 
peared to be particularly worthwhile because the 
high ulcer recurrence rate in period i resulted in lost 
employment ime and employability for at least four 
of our 10 patients. These effects were magnified in 
our medical center, where a rural population involves 
care for patients who live as far as 200 miles away. 
Travel time and costs for repeated clinic visits exerted 
a significant burden in period 1, but were not re- 
quired in period 2. Postoperative patients always 
require meticulous follow-up; however, after surgery 
these patients need be seen only at intervals of 6 to 
12 months. 
Ulcer recurrence rates are compliance-related and 
with the best nonoperative therapy 1,2,19 range from 
15% to 50% or more over intervals as long as 5 years. 
Nonoperative treatment might, on a superficial basis, 
be found to be relatively less expensive than operative 
treatment. The cost of treatment can be reduced in 
specialty venous clinics. For example, in the United 
Kingdom, over a 6-week period the per-patient cost 
was reported to be the equivalent of only $150 U.S. 2° 
This cost could not be duplicated in our clinics. Our 
institutional cost for 6 weekly visits is $400 including 
supplies. The loss of employment and sick time 
needed must also be taken into account. The cost of 
operative treatment in comparison with that of non- 
operative treatment requires further study. Skin graft- 
ing of large ulcers requires increased hospitalization 
rime, whereas treatment of small ulcers that do not 
need grafting can be given much more expeditiously 
on an ambulatory basis. 
Prospective comparisons with the nonoperarive 
treatment of small ulcers and lipodermatosclerosis 
using the newly developed subfascial endoscopically 
assisted perforator surgery (SEPS) TM will be of 
interest. With this procedure most patients can be 
managed on an ambulatory basis, but long-term 
results need to be compared with those of conven- 
tional techniques. Evaluation of synchronous bypass, 
valvuloplasty, or valve transplant to treat venous 
ulceration will also be required. Clearly, in the future 
more effective and rational surgical procedures for 
CVI will continue to evolve. At present, new patients 
who seek medical attention at the clinic with advanced 
skin changes as a result of venous disease are all 
evaluated by duplex scanning. Suitable candidates arc 
offered operative intervention as determined by the 
pattern of transmission of venous hypertension to 
affected skin area. 
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